Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene ...
The Humelink transmission project has received approval from the Minns Labor Government of New South Wales (NSW), Australia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback